NCT03744637 A Study of Single Doses of Frespaciguat (MK-5475) on Pulmonary Vascular Resistance (MK-5475-002) Status COMPLETED Phase PHASE1
NCT03738150 A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension Status COMPLETED Phase PHASE2
NCT03718780 Assessment of Continuous Measurement of Transcutaneous CO2 for Evaluation of Alveolar Dead Space During Exercise Status COMPLETED Phase NA
NCT03708146 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BIA 5-1058 Status COMPLETED Phase PHASE1
NCT03683186 A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension Status ENROLLING_BY_INVITATION Phase PHASE3
NCT03657095 A Study With BPS-314d-MR-PAH-303 in Participants With Pulmonary Arterial Hypertension Status TERMINATED Phase PHASE3
NCT03655704 Apabetalone for Pulmonary Arterial Hypertension: a Pilot Study Status COMPLETED Phase EARLY_PHASE1
NCT03626688 A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients Status COMPLETED Phase PHASE3
NCT03612115 Neuromuscular Electrical Stimulation in Pulmonary Arterial Hypertension Status COMPLETED Phase NA
NCT03602781 Study of PAH Subjects With LTOT Use That Have Demonstrated Improved Exercise Tolerance With the Use of Inhaled Nitric Status WITHDRAWN Phase PHASE3
NCT03556020 Phase 2 Study to Assess Safety, Tolerability and Efficacy of Once Weekly SC Pemziviptadil (PB1046) in Subjects With Symptomatic PAH Status TERMINATED Phase PHASE2
NCT03554330 Combined Use of Radiofrequency-ablation and Balloon-septostomy in the Creation of a Stable Inter-atrial Communication Status UNKNOWN Phase NA
NCT03554291 Repurposing a Histamine Antagonist to Benefit Patients With Pulmonary Hypertension Status COMPLETED Phase PHASE2
NCT03550729 Effects of Physical Training on Vascular Function as a Therapeutic Target in Pulmonary Hypertension Status ACTIVE_NOT_RECRUITING Phase NA